100.96

1.01% 1.01

After Hours: 100.10 -0.86 -0.85%

Irhythm Technologies Inc (IRTC)

Overview News Price History Option Chain Financials Discussions Forecast

Irhythm Technologies Inc stock is traded at $100.96, with a volume of 255.40K. It is up +1.01% in the last 24 hours and down -2.64% over the past month. iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Previous Close:

$99.95

Open:

$99.49

24h Volume:

255.40K

Relative Volume:

0.60

Market Cap:

$3.29B

Revenue:

$560.03M

Net Income/Loss:

$-150.66M

P/E Ratio:

-20.77

EPS:

-4.86

Net Cash Flow:

$-87.43M

1W Performance:

+2.20%

1M Performance:

-2.64%

6M Performance:

+61.56%

1Y Performance:

-9.44%

1-Day Range:

$99.49

$102.80

1-Week Range:

$95.95

$104.12

52-Week Range:

$55.92

$128.52

Irhythm Technologies Inc Stock (IRTC) Company Profile

Name

Irhythm Technologies Inc

Sector

Healthcare (1151)

Industry

Medical Devices (153)

Phone

415-632-5700

Address

699 8TH STREET, San Francisco, CA

Employee

2,000

Twitter

@iRhythmTech

Next Earnings Date

2024-10-30

Latest SEC Filings

IRTC's Discussions on Twitter

Compare IRTC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRTC Irhythm Technologies Inc	100.96	3.29B	560.03M	-150.66M	-87.43M	-4.86
ABT Abbott Laboratories	130.98	221.92B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.12	139.43B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	346.50	134.90B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	82.60	108.02B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	71.53	40.93B	5.72B	4.17B	259.90M	6.97

Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-03-24	Resumed	Wells Fargo	Equal Weight
Oct-04-24	Initiated	Goldman	Neutral
Jun-20-24	Upgrade	Wolfe Research	Peer Perform → Outperform
Dec-11-23	Upgrade	Citigroup	Neutral → Buy
Jul-19-23	Initiated	Robert W. Baird	Outperform
Feb-07-23	Initiated	Wells Fargo	Overweight
Nov-07-22	Upgrade	Wolfe Research	Underperform → Peer Perform
Jun-09-22	Downgrade	Citigroup	Buy → Neutral
Apr-06-22	Initiated	Wolfe Research	Underperform
Feb-24-22	Upgrade	Needham	Hold → Buy
Jan-18-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-12-22	Upgrade	BTIG Research	Neutral → Buy
Jan-11-22	Upgrade	Oppenheimer	Perform → Outperform
Dec-21-21	Resumed	Canaccord Genuity	Buy
Dec-17-21	Upgrade	JP Morgan	Neutral → Overweight
Dec-15-21	Upgrade	Citigroup	Neutral → Buy
Jun-02-21	Downgrade	Citigroup	Buy → Neutral
Apr-13-21	Downgrade	BTIG Research	Buy → Neutral
Apr-12-21	Downgrade	JP Morgan	Overweight → Neutral
Feb-26-21	Downgrade	Colliers Securities	Buy → Neutral
Jan-29-21	Reiterated	Needham	Hold
Nov-17-20	Downgrade	Oppenheimer	Outperform → Perform
Sep-11-20	Initiated	Needham	Hold
Sep-02-20	Initiated	Robert W. Baird	Neutral
Aug-07-20	Upgrade	Colliers Securities	Neutral → Buy
Aug-05-20	Upgrade	Oppenheimer	Perform → Outperform
Mar-05-20	Initiated	Citigroup	Buy
Feb-06-20	Initiated	BTIG Research	Buy
Jan-10-20	Initiated	William Blair	Outperform
Jan-08-20	Initiated	SunTrust	Buy
Oct-22-19	Initiated	Oppenheimer	Perform
Feb-20-19	Downgrade	Chardan Capital Markets	Buy → Neutral
Sep-13-18	Reiterated	Canaccord Genuity	Buy
Sep-06-18	Initiated	Chardan Capital Markets	Buy
Aug-02-18	Upgrade	Dougherty & Company	Sell → Neutral
Jul-16-18	Downgrade	Dougherty & Company	Neutral → Sell
Dec-01-17	Initiated	Dougherty & Company	Neutral

View All

Irhythm Technologies Inc Stock (IRTC) Latest News

Apr 18, 2025

Holter Monitoring System Market to Reach $1.91 Bn by 2034 | Miniaturization, Telehealth & Patient-Centric Innovations Fuel Growth - Global Banking | Finance | Review

Apr 18, 2025

Apr 17, 2025

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 | IRTC Stock News - GuruFocus

Apr 17, 2025

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 - The Manila Times

Apr 17, 2025

Digital Health Leader iRhythm Technologies Announces Q1 2025 Earnings Release Date - Stock Titan

Apr 17, 2025

Apr 16, 2025

iRhythm Technologies Announces Third Quarter 2024 Financial Results - ADVFN

Apr 16, 2025

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability | IRTC Stock News - GuruFocus

Apr 16, 2025

iRhythm's New Sustainability Report Reveals 89.5% Waste Reduction and Global Market Expansion - Stock Titan

Apr 16, 2025

SEC Form DEF 14A filed by iRhythm Technologies Inc. - Quantisnow

Apr 16, 2025

Turing Medical names Kevin King as president and CEO - MSN

Apr 16, 2025

Apr 15, 2025

Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer - 01net

Apr 15, 2025

Turing Medical Taps ex-iRhythm CEO Kevin King as Chief Exec - Medical Product Outsourcing

Apr 15, 2025

Turing Medical Names Transformative Med Tech Leader Kevin King a - GuruFocus

Apr 15, 2025

Healthcare Tech Veteran Who Led iRhythm's Success Story Now Leads Brain Mapping Innovator - Stock Titan

Apr 15, 2025

Apr 12, 2025

iRhythm Technologies (IRTC) Price Target Lowered by Truist Amid Market Uncertainties | IRTC Stock News - GuruFocus

Apr 12, 2025

Apr 11, 2025

Truist Cuts Price Target on iRhythm Technologies to $120 From $145, Keeps Buy Rating - marketscreener.com

Apr 11, 2025

Apr 10, 2025

3 Reasons IRTC is Risky and 1 Stock to Buy Instead - Yahoo Finance

Apr 10, 2025

Apr 08, 2025

Q4 Patient Monitoring Earnings Review: First Prize Goes To Masimo (NASDAQ:MASI) - Barchart.com

Apr 08, 2025

Apr 07, 2025

1 Small-Cap Stock Worth Your Attention and 2 to Question - Yahoo Finance

Apr 07, 2025

Cardiac Monitoring Devices Market Trends | Wearable & Remote - openPR.com

Apr 07, 2025

Apr 04, 2025

iRhythm Technologies, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights – IRTC - ACCESS Newswire

Apr 04, 2025

When Will iRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit? - Yahoo Finance

Apr 04, 2025

Apr 03, 2025

Would iRhythm Technologies (NASDAQ:IRTC) Be Better Off With Less Debt? - simplywall.st

Apr 03, 2025

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks - Yahoo Finance

Apr 03, 2025

Apr 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 02, 2025

Apr 01, 2025

Tempus AI Surges 43% YTD: Is It The Right Time To Invest In The Stock? - Barchart.com

Apr 01, 2025

iRhythm Unveils New Data Demonstrating Benefits of Long-Term Continuous Monitoring for Arrhythmia Detection - Diagnostic and Interventional Cardiology

Mar 31, 2025

New studies challenge efficacy of short-term heart monitors - Investing.com

Mar 31, 2025

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection - TradingView

Mar 31, 2025

Major Study Reveals Critical Flaw in Traditional Heart Monitoring: 64% of Arrhythmias Missed - Stock Titan

Mar 31, 2025

Mar 28, 2025

Commit To Buy iRhythm Technologies At $75, Earn 8.6% Annualized Using Options - Nasdaq

Mar 28, 2025

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against iRhythm Technologies, Inc. - PR Newswire

Mar 28, 2025

Mar 25, 2025

UPCOMING IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Mar 25, 2025

3 Healthcare Stocks in the Doghouse - Yahoo Finance

Mar 25, 2025

Mar 21, 2025

(IRTC) Trading Signals - news.stocktradersdaily.com

Mar 21, 2025

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers - The Globe and Mail

Mar 21, 2025

Mar 17, 2025

Tempus AI Surges 40% YTD: Are New Strategic Deals A Buy Signal? - Barchart

Mar 17, 2025

BREAKING ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages iRhythm Technologies, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline – IRTC - Business Wire

Mar 17, 2025

iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Mar 17, 2025

Mar 14, 2025

DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter - Yahoo Finance

Mar 14, 2025

Mar 13, 2025